Queen Mary, University of London Researchers’ Bayesian Meta-Analysis of Ivermectin Indicates Efficacy Targeting COVID-19

Queen Mary, University of London Researchers’ Bayesian Meta Analysis of Ivermectin Indicates Efficacy Targeting COVID-19

Recently, two researchers from Queen Mary, University of London, conducted a peer-reviewed meta-analysis evaluating ivermectin (Bryant et al, 2021) and concluded that this antiparasitic drug is a cheap and effective treatment for reducing COVID-19 deaths. Importantly, these conclusions were in stark contrast to those of a later study (Roman et al, 2021). Although (Roman et al, 2021) applied the same classical statistical approach to meta-analysis, and produced similar results based on a subset of the same trials data used by (Bryant et al), they claimed there was insufficient quality of evidence to support the conclusion Ivermectin was effective. The Queen Mary, University of London investigators apply a Bayesian approach, to a subset of the same trial data, to test several causal hypotheses linking COVID-19 severity and ivermectin to mortality and produce an alternative analysis to the classical approach. Applying diverse alternative analysis methods, which reach the same conclusions, should increase overall confidence in the result. The authors demonstrate that there is overwhelming evidence to support a causal link between ivermectin, COVID-19 severity and mortality, and: i) fo...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee